BB102

· Broadenbio Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BB102, covering 2025-11-17 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma [Phase 2]